Mucosal and systemic immune modulation by Trichuris trichiura in a self-infected individual

Parasite Immunology

Volumn 39, Issue 1, 2017, Pages

  Dige, A ^a   Rasmussen, T K ^a,b   Nejsum, P ^c   Hagemann Madsen, R ^d   Williams, A R ^c   Agnholt, J ^a   Dahlerup, J F ^a   Hvas, C L ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d LILLEBAELT HOSPITAL   (Denmark)

Author keywords

helminths; immunology; trichiura; Trichuris

Indexed keywords

CALGRANULIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 21; INTERLEUKIN 22; MEBENDAZOLE; RETINOID RELATED ORPHAN RECEPTOR GAMMA; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 3; TRANSFORMING GROWTH FACTOR BETA; CYTOKINE;

ADULT; ANTIHELMINTHIC THERAPY; ARTICLE; CAMPYLOBACTER ENTERITIS; CASE REPORT; CD4+ T LYMPHOCYTE; COLON BIOPSY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; HUMAN; HUMAN TISSUE; IMMUNITY; IMMUNOMODULATION; MALE; MICROBIAL COLONIZATION; MUCOSAL IMMUNITY; PARASITE CLEARANCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REGULATORY T LYMPHOCYTE; SYSTEMIC IMMUNITY; TH1 CELL; TH17 CELL; TH2 CELL; TRICHURIASIS; TRICHURIS TRICHIURA; ANIMAL; CAMPYLOBACTERIOSIS; COMPLICATION; IMMUNOLOGY; INTESTINE MUCOSA; METABOLISM; TRICHURIS;

ADULT; ANIMALS; CAMPYLOBACTER INFECTIONS; CYTOKINES; HUMANS; IMMUNITY, MUCOSAL; INTESTINAL MUCOSA; MALE; MEBENDAZOLE; T-LYMPHOCYTES, REGULATORY; TRICHURIASIS; TRICHURIS;

EID: 85006927651     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/pim.12394     Document Type: Article

References (37)

1. Elliott DE, Weinstock JV. Helminth-host immunological interactions: prevention and control of immune-mediated diseases. Ann N Y Acad Sci. 2012;1247:83–96.
2. Khan AR, Fallon PG. Helminth therapies: translating the unknown unknowns to known knowns. Int J Parasitol. 2013;43:293–299.
3. Weinstock JV. Autoimmunity: the worm returns. Nature. 2012;491:183–185.
4. Wolff MJ, Broadhurst MJ, Loke P. Helminthic therapy: improving mucosal barrier function. Trends Parasitol. 2012;28:187–194.
5. Maizels RM, Yazdanbakhsh M. Immune regulation by helminth parasites: cellular and molecular mechanisms. Nat Rev Immunol. 2003;3:733–744.
6. McSorley HJ, Hewitson JP, Maizels RM. Immunomodulation by helminth parasites: defining mechanisms and mediators. Int J Parasitol. 2013;43:301–310.
7. Allen JE, Maizels RM. Diversity and dialogue in immunity to helminths. Nat Rev Immunol. 2011;11:375–388.
8. Taylor MD, van der Werf N, Maizels RM. T cells in helminth infection: the regulators and the regulated. Trends Immunol. 2012;33:181–189.
9. Grogan JL, Kremsner PG, Deelder AM, Yazdanbakhsh M. Antigen-specific proliferation and interferon-gamma and interleukin-5 production are down-regulated during Schistosoma haematobium infection. J Infect Dis. 1998;177:1433–1437.
10. King CL, Mahanty S, Kumaraswami V, Abrams JS, Regunathan J, Jayaraman K, Ottesen EA, Nutman TB. Cytokine control of parasite-specific anergy in human lymphatic filariasis. Preferential induction of a regulatory T helper type 2 lymphocyte subset. J Clin Invest. 1993;92:1667–1673.
11. Metenou S, Dembele B, Konate S, Dolo H, Coulibaly SY, Coulibaly YI, Diallo AA, Soumaoro L, Coulibaly ME, Sanogo D, Doumbia SS, Traoré SF, Mahanty S, Klion A, Nutman TB. At homeostasis filarial infections have expanded adaptive T regulatory but not classical Th2 cells. J Immunol. 2010;184:5375–5382.
12. Nausch N, Midzi N, Mduluza T, et al. Regulatory and activated T cells in human Schistosoma haematobium infections. PLoS ONE. 2011;6:e16860.
13. Bager P, Arnved J, Ronborg S, et al. Trichuris suis ova therapy for allergic rhinitis: a randomized, double-blind, placebo-controlled clinical trial. J Allergy Clin Immunol. 2010;125:123–130.
14. Feary JR, Venn AJ, Mortimer K, et al. Experimental hookworm infection: a randomized placebo-controlled trial in asthma. Clin Exp Allergy. 2010;40:299–306.
15. Summers RW, Elliott DE, Urban JF, et al. Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial. Gastroenterology. 2005;128:825–832.
16. Summers RW, Elliott DE, Urban JF, et al. Trichuris suis therapy in Crohn's disease. Gut. 2005;54:87–90.
17. Daveson AJ, Jones DM, Gaze S, et al. Effect of hookworm infection on wheat challenge in celiac disease – a randomised double-blinded placebo controlled trial. PLoS ONE. 2011;6:e17366.
18. Fleming JO, Isaak A, Lee JE, et al. Probiotic helminth administration in relapsing-remitting multiple sclerosis: a phase 1 study. Mult Scler. 2011;17:743–754.
19. Correale J, Farez M. Association between parasite infection and immune responses in multiple sclerosis. Ann Neurol. 2007;61:97–108.
20. Correale J, Farez MF. The impact of parasite infections on the course of multiple sclerosis. J Neuroimmunol. 2011;233:6–11.
21. Broadhurst MJ, Leung JM, Kashyap V, et al. IL-22 + CD4 + T cells are associated with therapeutic Trichuris trichiura infection in an ulcerative colitis patient. Sci Transl Med 2010;2:60ra88.
22. World Health Organization. Soil-transmitted helminthiases: Eliminating soil-transmitted helminthiasis as a public health problem in children: progress report 2001–2010 and strategic plan 2011–2020. 2012
23. Roepstorff A, Nansen P, Epidemiology, diagnosis and control of helmith parasites of swine. Food and Agriculture Organization of the United Nations. 1998.
24. Nissen S, Al-Jubury A, Hansen TV, Olsen A, Christensen H, Thamsborg SM, Nejsum P. Genetic analysis of Trichuris suis and Trichuris trichiura recovered from humans and pigs in a sympatric setting in Uganda. Vet Parasitol. 2012;188:68–77.
25. Dige A, Støy S, Rasmussen TK, Kelsen J, Hvas CL, Sandahl TD, Dahlerup JF, Deleuran B, Agnholt J. Increased levels of circulating Th17 cells in quiescent versus active Crohn's disease. J Crohns Colitis. 2013;7:248–255.
26. Dige A, Hvas CL, Deleuran B, et al. Scand J Gastroenterol. 2011;46:1206–1214.
27. Law JP, Hirschkorn DF, Owen RE, Biswas HH, Norris PJ, Lanteri MC. The importance of Foxp3 antibody and fixation/permeabilization buffer combinations in identifying CD4 + CD25 + Foxp3 + regulatory T cells. Cytometry A. 2009;75:1040–1050.
28. Kringel H, Roepstorff A. Trichuris suis excretory/secretory antigen-specific antibodies in serum from single-inoculated pigs. Parasite Immunol. 2007;29:327–330.
29. Olsen A, Namwanje H, Nejsum P, Roepstorff A, Thamsborg SM. Albendazole and mebendazole have low efficacy against Trichuris trichiura in school-age children in Kabale District, Uganda. Trans R Soc Trop Med Hyg. 2009;103:443–446.
30. Rook GA. Review series on helminths, immune modulation and the hygiene hypothesis: the broader implications of the hygiene hypothesis. Immunology. 2009;126:3–11.
31. Bundy DA, Cooper ES. Trichuris and trichuriasis in humans. Adv Parasitol. 1989;28:107–173.
32. Sherwood RA. Faecal markers of gastrointestinal inflammation. J Clin Pathol. 2012;65:981–985.
33. Mansfield LS, Gauthier DT, Abner SR, Jones KM, Wilder SR, Urban JF. Enhancement of disease and pathology by synergy of Trichuris suis and Campylobacter jejuni in the colon of immunologically naive swine. Am J Trop Med Hyg. 2003;68:70–80.
34. Wu S, Li RW, Li W, Beshah E, Dawson HD, Urban JF Jr. Worm burden-dependent disruption of the porcine colon microbiota by Trichuris suis infection. PLoS ONE. 2012;7:e35470.
35. Abner SR, Hill DE, Turner JR, Black ED, Bartlett P, Urban JF, Mansfield LS. Response of intestinal epithelial cells to Trichuris suis excretory-secretory products and the influence on Campylobacter jejuni invasion under in vitro conditions. J Parasitol. 2002;88:738–745.
36. Stephenson LS, Latham MC, Ottesen EA. Malnutrition and parasitic helminth infections. Parasitology. 2000;121(Suppl.):S23–S38.
37. Shin JL, Gardiner GW, Deitel W, Kandel G. Does whipworm increase the pathogenicity of Campylobacter jejuni? A clinical correlate of an experimental observation. Can J Gastroenterol. 2004;18:175–177.